Vir Biotechnology VIR
NASDAQ VIR
$13.10 -0.05 (-0.38%)
As of: Nov 11, 2026 · 10:17 AM EST

Vir Biotechnology (VIR) Return on Assets [ROA] (2019 - 2026)

Updated

Vir Biotechnology (VIR) reported Return on Assets [ROA] of -15.88% for Q3 2026, up 29.29 percentage points from -45.18% a year earlier and up 6.58 percentage points from the prior quarter.

Analysis

Vir Biotechnology (VIR) Return on Assets [ROA] (2019 - 2026) Analysis & Trends

For FY2025, Vir Biotechnology posted Return on Assets [ROA] of -36.47%, down 5.01 percentage points from FY2024.

  • Return on Assets [ROA] has declined for four consecutive years, though with a five-year change of +5.27 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -31.46% in FY2024 (-5.41 pp), -26.06% in FY2023 (-47.75 pp), 21.69% in FY2022 (-15.11 pp) and 36.80% in FY2021 (+78.54 pp).
  • The Q3 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q2 2023.
  • Year over year, Return on Assets [ROA] gained in two of the last eight quarters, with an average year-over-year change of -0.46 percentage points.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q1 2022 (a gain of 88.24 percentage points); the low point was Q3 2023 (a drop of 71.01 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at -22.47% (Q2 2026), -43.65% (Q1 2026) and -43.32% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Vir Biotechnology 2.23 Bn 313.19 Mn 188,000.00 -15.88%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -15.88%
Jun 30, 2026 -22.47%
Mar 31, 2026 -43.65%
Dec 31, 2025 -43.32%
Sep 30, 2025 -45.18%
Jun 30, 2025 -44.01%
Mar 31, 2025 -42.69%
Dec 31, 2024 -36.03%
Sep 30, 2024 -33.67%
Jun 30, 2024 -27.89%
Mar 31, 2024 -29.06%
Dec 31, 2023 -31.04%
Sep 30, 2023 -28.01%
Jun 30, 2023 -10.67%
Mar 31, 2023 -5.26%
Dec 31, 2022 18.76%
Sep 30, 2022 43.00%
Jun 30, 2022 39.15%
Mar 31, 2022 50.24%
Dec 31, 2021 33.41%
API Access

Vir Biotechnology Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VIR&period=max&api_key=YOUR_API_KEY